Posted: April 4, 2013
By: Morrison & Foerster
MoFo BioMeter reports a robust 2013 for biotech licensing deals. Aided by a healthy surge in Q4 transactions, up-front payments for licensing deals for all of 2013 increased more than 60% from 2012, averaging $33.9 million. New in this issue is a survey of 2013 biotech hot spots which shows San Francisco on top followed by the Mid-Atlantic region, New York/New Jersey and San Diego, with Germany the international leader.
Share this content with your network.
By clicking this 'Download Now' box, you consent to BioCentury forwarding your information
to the company that wrote this White Paper and you agree that said company can use